Together the results, obtained through modified stromal TGF-β signaling in mice with those obtained using human fibroblast and epithelial cell recombination, suggest that stromal–epithelial interactions can have a significant impact on the regulation of adjacent carcinoma initiation and progression in vivo. Here, TGFB1 is linked to carcinoma.